Results 1 to 10 of about 76,080 (116)

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer [PDF]

Biomedicines, 2022
Positron emission tomography (PET) incorporated with X-ray computed tomography (PET/CT) or magnetic resonance imaging (PET/MRI) is increasingly being used as a diagnostic tool for prostate cancer (PCa).
Mei Li, Roman Zelchan, Anna Orlova
doaj   +2 more sources

Emerging PET Imaging Agents and Targeted Radioligand Therapy: A Review of Clinical Applications and Trials [PDF]

Tomography
Targeted radioligand therapy (RLT) is an emerging field in anticancer therapeutics with great potential across tumor types and stages of disease. While much progress has focused on agents targeting somatostatin receptors and prostate-specific membrane ...
Maierdan Palihati, Jeeban Paul Das, Randy Yeh, Kathleen Capaccione   +3 more
doaj   +2 more sources

Tellurium-118 as a novel radionuclide for long-term positron emission tomography [PDF]

Scientific Reports
Positron emission tomography (PET) is a powerful imaging modality that tracks positron-emitting radionuclides, enabling non-invasive and high-resolution visualization of biological targets and processes.
Sotaro Miyao, Toshimitsu Momose, Masako Kawabata, Yuki Mitsuya, Atsuko Nakanishi Ozeki, Arisa Hayashi, Xindi Qiu, Yousuke Kanayama, Hiromitsu Haba, Izumi O. Umeda, Jaewoong Jang, Youichiro Wada, Nobuyoshi Akimitsu, Hiroyuki Takahashi   +13 more
doaj   +2 more sources

Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents

Pharmaceuticals, 2021
Radiolabeled fluorescent dyes are decisive for bimodal imaging as well as highly in demand for nuclear- and optical imaging. Silicon-rhodamines (SiRs) show unique near-infrared (NIR) optical properties, large quantum yields and extinction coefficients as
Thines Kanagasundaram, Markus Laube, Johanna Wodtke, Carsten Sven Kramer, Sven Stadlbauer, Jens Pietzsch, Klaus Kopka   +6 more
doaj   +3 more sources

Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma

Diagnostics, 2022
Melanoma is a deadly disease that often exhibits relentless progression and can have both early and late metastases. Recent advances in immunotherapy and targeted therapy have dramatically increased patient survival for patients with melanoma.
Laetitia Vercellino, Dorine de Jong, Laurent Dercle, Benoit Hosten, Brian Braumuller, Jeeban Paul Das, Aileen Deng, Antoine Moya-Plana, Camry A’Keen, Randy Yeh, Pascal Merlet, Barouyr Baroudjian, Mary M. Salvatore, Kathleen M. Capaccione   +13 more
doaj   +1 more source

Approaches to PET Imaging of Glioblastoma

Molecules, 2020
Glioblastoma multiforme (GBM) is the deadliest type of brain tumor, affecting approximately three in 100,000 adults annually. Positron emission tomography (PET) imaging provides an important non-invasive method of measuring biochemically specific targets
Lindsey R. Drake, Ansel T. Hillmer, Zhengxin Cai   +2 more
doaj   +1 more source

Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET)

Molecules, 2020
The need for increasingly personalized medicine solutions (precision medicine) and quality medical treatments, has led to a growing demand and research for image-guided therapeutic solutions.
Pedro M. O. Gomes, Artur M. S. Silva, Vera L. M. Silva   +2 more
doaj   +1 more source

PET/CT for Predicting Occult Lymph Node Metastasis in Gastric Cancer

Current Oncology, 2022
A portion of gastric cancer patients with negative lymph node metastasis at an early stage eventually die from tumor recurrence or advanced metastasis.
Danyu Ma, Ying Zhang, Xiaoliang Shao, Chen Wu, Jun Wu   +4 more
doaj   +1 more source

The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions

Frontiers in Oncology, 2023
Recently, the morbidity and mortality of pancreatic cancer have been increasing year by year. Because of its deep anatomical location and because most presented patients often suffer from abdominal pain or jaundice, it is difficult to diagnose pancreatic
Jindan Li, Chaojiang Fu, Sheng Zhao, Yongzhu Pu, Fake Yang, Shuguang Zeng, Conghui Yang, Hongqiang Gao, Long Chen   +8 more
doaj   +1 more source

PET Imaging in Animal Models of Alzheimer’s Disease

Frontiers in Neuroscience, 2022
The successful development and translation of PET imaging agents targeting β-amyloid plaques and hyperphosphorylated tau tangles have allowed for in vivo detection of these hallmarks of Alzheimer’s disease (AD) antemortem.
Baosheng Chen, Bernadette Marquez-Nostra, Erika Belitzky, Takuya Toyonaga, Jie Tong, Yiyun Huang, Zhengxin Cai   +6 more
doaj   +1 more source